Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

norameda, uab - ciprofloksacinas - infuzinis tirpalas - 2 mg/ml - ciprofloxacin

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

steriscience b.v. - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 500 mg - meropenem

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

as kalceks - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 500 mg - meropenem

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

as kalceks - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 1 g - meropenem

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

qilu pharma spain s.l. - meropenemas - milteliai injekciniam ar infuziniam tirpalui - 1 g - meropenem

Euroopan unioni - liettua - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artritas, reumatas - imunosupresantai - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumianetą galima vartoti kaip monoterapiją arba kartu su metotreksatu. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Euroopan unioni - liettua - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials sisteminio naudojimo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

krka, d.d., novo mesto - acetilsalicilo rūgštis - skrandyje neirios tabletės - 100 mg; 75 mg; 160 mg - acetylsalicylic acid

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

us pharmacia sp. z o.o. - paracetamolis - granulės paketėlyje - 250 mg - paracetamol

Liettua - liettua - SMCA (Valstybinė vaistų kontrolės tarnyba)

pharmaceutical works polpharma s.a. - cefotaksimas - milteliai injekciniam ar infuziniam tirpalui - 1 g - cefotaxime